IVF denied as duplicate or overlapping therapy by Humana?

Humana's specific coverage criteria for IVF are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied IVF as Duplicate Therapy — and Why That Logic Usually Fails on Appeal

A duplicate-therapy denial means Humana has determined that IVF duplicates another fertility treatment the plan has already authorized or that you are already receiving. This denial category is uncommon for IVF and is frequently the result of a coding or administrative error — for example, a prior IUI cycle or a fertility preservation procedure being miscoded in a way that appears equivalent to IVF. It can also occur when a new IVF cycle is requested while a prior authorization from a previous cycle is still technically open in Humana's system.

## Why This Denial Is Appealable

IVF is a distinct clinical procedure with a specific indication, protocol, and outcome profile. It is not interchangeable with IUI, ovulation induction, or other fertility interventions. If Humana has identified a supposedly duplicative treatment, your appeal should name that treatment and explain — through your physician — why it is clinically distinct from IVF, why it does not address your specific diagnosis with the same effectiveness, and why your plan of care requires IVF specifically. Administrative errors (open prior authorizations, miscoding) should be corrected with documentation and a written request for reconsideration before or alongside a formal internal appeal.

## Your Federal Appeal Rights

• Internal appeal — file within 180 days of the denial. Humana must respond within 30 days for a pre-service appeal.
• External review (ACA §2719) — if the internal appeal is denied, request independent external review within four months of the final denial. The IRO decision is binding on Humana.
• Expedited review — if your physician certifies urgent need, a 72-hour external-review decision is available.
• ERISA §503 — if your plan is employer self-funded, full-and-fair review rights apply, including potential federal court review.

## What to Gather

• Humana's denial letter — identify exactly which service or prior authorization Humana claims duplicates IVF.
• Distinction documentation — records confirming that the supposedly duplicative service is a separate procedure with a different date, indication, or clinical purpose.
• Physician letter — a statement from your reproductive endocrinologist explaining why IVF is not duplicative of any prior or concurrent treatment, and why it is the appropriate next step in your individualized care plan.
• Coding review — if the denial stems from a billing or coding issue, obtain a corrected claim or a letter from the billing office clarifying the procedure codes involved.
• Humana's published coverage policy — pull the current IVF/infertility coverage determination and identify any duplicate-therapy language to address directly.

## Criteria-Mapping Structure

For each basis Humana cites for the duplicate-therapy determination, build a two-column table: the stated basis in the left column, and the specific record, date, or physician statement that distinguishes your IVF request from that basis in the right column. Precision here is critical — vague rebuttals rarely succeed on this denial type.